EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Comparable efficacy of oral bendamustine versus intravenous administration in treating hematologic malignancies

Megan J Cracchiolo, Lisa Davis, Andrew P Matiatos, Dan W Davini, Muhammad Husnain, Richard J Simpson iD, Vasilios Voudouris, Emmanuel Katsanis iD

Cancer Chemotherapy and Pharmacology · 2024

DOI: 10.1007/s00280-024-04688-y ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2024. Verfasst von Megan J Cracchiolo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Arizona, 1501 N. Campbell Ave., PO Box 245073, Tucson, AZ, 85724-5073, USA. Hauptthemen laut MEDLINE: Bendamustine Hydrochloride, Administration, Intravenous, Hematologic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, University of Arizona Cancer Center Support Grant , NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bendamustine HydrochlorideAdministration, IntravenousHematologic NeoplasmsAnimalsHumansAdministration, OralMiceCell Line, TumorXenograft Model Antitumor AssaysMice, Inbred NODMice, SCIDMultiple MyelomaAntineoplastic Agents, Alkylating

Stichwörter der Autor:innen

Acute lymphoblastic leukemiaBendamustineLymphomaMultiple myelomaPharmacokinetics

Substanzen

Bendamustine HydrochlorideAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • Department of Pediatrics, University of Arizona, 1501 N. Campbell Ave., PO Box 245073, Tucson, AZ, 85724-5073, USA.
  • R. Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ, USA.
  • Department of Medicine, University of Arizona, Tucson, AZ, USA.
  • The University of Arizona Cancer Center, Tucson, AZ, USA.
  • Department of Immunobiology, University of Arizona, Tucson, AZ, USA.
  • School of Nutritional Sciences and Wellness, University of Arizona, Tucson, AZ, USA.

ORCID-Profile: Richard J Simpson, Emmanuel Katsanis

Förderung

  • NCI NIH HHS
  • University of Arizona Cancer Center Support Grant , NCI

Zitieren

APA

Cracchiolo, M. J., Davis, L., Matiatos, A. P., Davini, D. W., Husnain, M., Simpson, R. J., Voudouris, V., & Katsanis, E. (2024). Comparable efficacy of oral bendamustine versus intravenous administration in treating hematologic malignancies. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04688-y

Vancouver

Cracchiolo MJ, Davis L, Matiatos AP, Davini DW, Husnain M, Simpson RJ, et al. Comparable efficacy of oral bendamustine versus intravenous administration in treating hematologic malignancies. Cancer Chemotherapy and Pharmacology. 2024. doi:10.1007/s00280-024-04688-y

BibTeX
@article{Cracchiolo2024,
  author = {Cracchiolo, Megan J and Davis, Lisa and Matiatos, Andrew P and Davini, Dan W and Husnain, Muhammad and Simpson, Richard J and Voudouris, Vasilios and Katsanis, Emmanuel},
  title = {Comparable efficacy of oral bendamustine versus intravenous administration in treating hematologic malignancies},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2024},
  doi = {10.1007/s00280-024-04688-y}
}
Kostenlos starten →